Medtronic Analyst Ratings
Analysts' Opinions Are Mixed on These Healthcare Stocks: Canopy Growth (CGC), Medtronic (MDT) and Teladoc (TDOC)
Needham Maintains Medtronic(MDT.US) With Hold Rating
Citi Maintains Medtronic(MDT.US) With Hold Rating, Maintains Target Price $92
Analysts Offer Insights on Healthcare Companies: Medtronic (MDT), Organon (OGN) and Inventiva (IVA)
Barclays Maintains Medtronic(MDT.US) With Buy Rating, Maintains Target Price $109
BTIG Maintains Medtronic(MDT.US) With Hold Rating
BTIG Maintains Medtronic(MDT.US) With Hold Rating
Medtronic (MDT) Gets a Hold From Piper Sandler
Truist Financial Maintains Medtronic(MDT.US) With Hold Rating
Truist Financial Sticks to Its Hold Rating for Medtronic (MDT)
Citi Maintains Medtronic(MDT.US) With Hold Rating, Maintains Target Price $92
Citi Maintains Medtronic(MDT.US) With Hold Rating, Maintains Target Price $92
BofA Securities Maintains Medtronic(MDT.US) With Buy Rating, Maintains Target Price $100
TD Cowen Maintains Medtronic(MDT.US) With Buy Rating, Maintains Target Price $95
TD Cowen Reaffirms Their Buy Rating on Medtronic (MDT)
BofA Securities Maintains Medtronic(MDT.US) With Buy Rating, Announces Target Price $100
Medtronic's Strategic Growth Catalysts: RDN Coverage and Emerging Technologies Drive Buy Rating
Bernstein Adjusts Price Target on Medtronic to $93 From $97, Keeps Outperform Rating
Bernstein Maintains Medtronic(MDT.US) With Buy Rating, Cuts Target Price to $93